Emigh James F Insider Trades

Insider Trading History

Track insider trading activity for Emigh James F. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
Vp, Corporate Development
Holding Value $94.8 474,042 shares
Last Trade
Feb 24, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
Vp, Corporate Development
Holding Value $96.3 481,592 shares
Last Trade
Feb 24, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
Vp, Corporate Development
Holding Value $0 0 shares
Last Trade
Feb 24, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
Vp, Corporate Development
Holding Value $92.3 461,592 shares
Last Trade
Jan 04, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
Vp, Corporate Development
Holding Value $93.8 468,994 shares
Last Trade
Jan 04, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
Vp, Corporate Development
Holding Value $8.93 44,666 shares
Last Trade
Jan 04, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
Vp, Corporate Development
Holding Value $12.9 64,666 shares
Last Trade
Jan 04, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
Vp, Corporate Development
Holding Value $88.9 444,327 shares
Last Trade
Jan 02, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
Vp, Corporate Development
Holding Value $13.9 69,333 shares
Last Trade
Jan 02, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
VP Corporate Development
Holding Value $4 20,000 shares
Last Trade
Dec 11, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
VP Corporate Development
Holding Value $12 60,000 shares
Last Trade
Dec 11, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
VP Corporate Development
Holding Value $87.9 439,660 shares
Last Trade
Dec 14, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
VP Corporate Development
Holding Value $2.8 14,000 shares
Last Trade
Dec 11, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
VP Corporate Development
Holding Value $2.8 14,000 shares
Last Trade
Aug 09, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
VP Corporate Development
Holding Value $2.8 14,000 shares
Last Trade
Dec 08, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
VP Corporate Development
Holding Value $4 20,000 shares
Last Trade
Dec 10, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
VP Corporate Development
Holding Value $10.8 54,000 shares
Last Trade
Dec 11, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
VP Corporate Development
Holding Value $39.7 198,304 shares
Last Trade
May 16, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
VP Corporate Development
Holding Value $36.7 183,304 shares
Last Trade
Jan 24, 2014 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Acura Pharmaceuticals
Acura Pharmaceuticals ACUR
VP Corporate Development
Holding Value $0 0 shares
Last Trade
Jan 24, 2014 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up